Thirteen of the 15 prostate cancer patients treated with a Rice University-developed therapy were cancer-free after one year, a new study shows. The study, published Monday in the journal Proceedings of the National Academy of Sciences, is the most recent step in a...
In an ongoing clinical trial, researchers are using gold nanoparticles to target prostate cancer cells. So far, the results are promising, and side effects are relatively minimal. Nanotechnology may help improve prostate cancer treatment and reduce side effects....
Prostate cancer patients may soon have a new treatment option: gold nanoparticles. Current treatments, such as radiation therapy or surgery, come with risks such as dangerous reactions to anaesthetics, uncontrolled bleeding, fatal blood clots, impotence, erectile...
Two commercial partners of Houston-based biotech firm Nanospectra Biosciences Inc. plan to launch consumer products in the U.S. in 2019, according to an Oct. 30 release from the company. Having previously been funded only by private equity investments and grant money,...
Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, provides an update on notable accomplishments and its corporate priorities for 2018. “In 2017, we focused on moving AuroLase®, the...
Recent Comments